April 19, 2017 NIAID Funding News
Read this full issue online at https://www.niaid.nih.gov/grants-contracts/niaid-funding-news-april-19-2017
Feature Articles
Where Are They Now? NIAID’s Apply for a Grant Webpages
In Part III of our series about popular relocated content, we cover the Apply for a Grant section—located within the “Grants & Contracts” tab of the top navigation bar.
Opportunities and Resources
Another Chance To Join the CFAR Program
NIH’s Centers for AIDS Research program supports research coordination, emerging research opportunities, and shared core facilities among institutions that receive significant HIV/AIDS funding from NIH.
Provide Manufacturing and Characterization Services for Vaccines and Other Biologics
A new request for proposals seeks services to develop multiple vaccines and biologic candidates that emerge from third-party sources.
Contractors: New RFP for Developing Interventional Agents for Infectious Diseases
NIAID anticipates awarding 10 multiple award indefinite quantity contracts and expects the performance period to begin summer of 2018.
Grantees: Act Quickly To Take Advantage of Cancer Immunotherapy Opportunity
For a limited time, administrative supplements are available to fund collaborative pilot projects seeking to reduce the incidence or severity of auto-inflammatory or autoimmune adverse events following cancer immunotherapy.
In The News
Guidance on Citing Interim Research Products in NIH Grant Applications
Investigators who want to accelerate dissemination and enhance the rigor of their work can now cite interim research products anywhere other research products are cited in a grant application or progress report.
Coming Soon: Opportunity To Add Regenerative Medicine Component to Ongoing Research
The 21st Century Cures Act provides funding to further the field of regenerative medicine using adult stem cells, including autologous cells.
News Briefs
- Your Application Will Be Withdrawn if You Don’t Follow NIH’s Appendix Policy
- R03, R21 Opportunities on Primary Immunodeficiency Diseases Will Expire Early
- Several BD2K Roadmap Initiatives Cancelled, New Initiatives Planned
Advice Corner
Understanding Indirect Costs
Having trouble distinguishing between direct and indirect costs for your federally funded research project? We’ve listed a few key points to help you better understand the difference.
Reader Questions
New Funding Opportunities
- PAR-17-254, Lasker Clinical Research Scholars Program (Si2/R00)
- RFA-AI-17-010, Dysregulation of Immune Cell Regulatory Pathways by Mtb in the Context of HIV Infection (R61/R33)
See other announcements at Opportunities & Announcements.
Send suggestions or comments to deaweb@niaid.nih.gov.
No hay comentarios:
Publicar un comentario